Browsing Category

44450 posts

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI, Feb. 23, 2025 /PRNewswire/ — BioCity Biopharma (BioCity) announced that its selective…

China committed to acting as an 'enabler'

BEIJING, Feb. 25, 2025 /PRNewswire/ — A report from People’s Daily: Recently,…
Kerry Establishes Local Manufacturing Partnership for Taste Solutions in Pakistan

Kerry Establishes Local Manufacturing Partnership for Taste Solutions in Pakistan

KARACHI, Pakistan, Feb. 25, 2025 /PRNewswire/ — Kerry, a global leader in taste…

How 51Talk is Redefining Online Education Through AI–from the Boardroom to the Classroom

SINGAPORE, Feb. 25, 2025 /PRNewswire/ — 51Talk, an online English language education platform,…

Consensus concludes sold-out debut event in Hong Kong and announces return to Asia in 2026

The Hong Kong Convention and Exhibition Centre reached maximum capacity, with nearly…

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world’s first anti-PD-L1 monoclonal antibody approved for the treatment…
JACKY CHEUNG BREAKS RECORD WITH 1000 SHOWS ACROSS 10 TOURS, A MILESTONE IN CHINESE MUSIC HISTORY

JACKY CHEUNG BREAKS RECORD WITH 1000 SHOWS ACROSS 10 TOURS, A MILESTONE IN CHINESE MUSIC HISTORY

BEIJING, Feb. 25, 2025 /PRNewswire/ — Jacky Cheung, known as the "God…

Lessons from Japan's AMR Response for the Global Community

https://iris.who.int/handle/10665/380481 TOKYO, Feb. 25, 2025 /PRNewswire/ — World Health Organization (WHO) Regional…